Navigation Links
Global biotech firm partners with CHEO researcher to address a technology gap in infectious disease
Date:10/3/2011

OTTAWA, ON October 3, 2011 The Children's Hospital of Eastern Ontario (CHEO) Research Institute is pleased to announce that one of its principal investigators in infectious disease has signed a contract with Life Technologies, an internationally renowned biotech tools company headquartered in Carlsbad, California, to share information that will help to develop tests that uniquely amplify and detect the DNA coding for infectious diseases. Dr. Robert Slinger will focus on bacteria that cause severe infectious diseases.

"I believe Life Technologies to be a leader in its field, so it was an honor to be approached about contributing to this project," said Dr. Slinger, a CHEO Medical Microbiologist and Pediatric Infectious Diseases physician. "Life Technologies is one of the only companies in the world that has the full suite of technology to look at detection of infectious disease agents from extracting DNA and RNA from a sample to amplifying and detecting the results. I think they're ahead of the curve yet again, by bringing microbial testing to their innovation roadmap."

Dr. Slinger and Life Technologies are partnering with the objective to co-develop microbial detection tests. In short, they will identify the unique DNA sequence of targeted infectious disease pathogens which will ultimately be used to create tests that will rapidly and clearly indicate when a targeted infectious agent has been identified in a patient sample. Samples will be tested with "all-inclusive" panels that include tests for large numbers (e.g. 30-50) of infectious agents. This approach will ensure that all possible causes of the patient's infection are looked for at the same time, which Dr. Slinger believes will ultimately lead to better antibiotic treatment for patients.

"Dr. Slinger is well known as one of the first to use molecular panel technology to test for infectious disease in humans," said Astrid Ferlinz, Life Technologies' Global Market Development Manager, Darmstadt, Germany. "We're now embarking on a strategic partnership with Dr. Slinger that will one day alter how we look for infectious disease to help patients; but also to protect the public from contracting serious infections that can't be detected by current lab methods (for instance, consider the E. coli outbreak in Germany this spring)."


'/>"/>

Contact: Adrienne Vienneau
avienneau@cheo.on.ca
613-737-7600 x4144
Children's Hospital of Eastern Ontario Research Institute
Source:Eurekalert

Related medicine news :

1. Embedded Mobile & M2M Device revenues to Rise to Almost $19 Billion Globally by 2014, Says Juniper Research
2. International Diabetes Federation awards $2 million to 9 global diabetes research projects
3. Virtual Global Highlights Top Ten Misconceptions about Cloud Computing
4. Global Health Defined as Public Health in a New Lancet Commentary by the Association of Schools of Public Health (ASPH)
5. Dr Yaghouti of Global Laser Vision Receives Patient's Choice Award for 2009
6. Bioniche Achieves Two Additional Milestones Under Licensing Agreement; Endo Takes up Global Rights
7. Now Serving 9 Billion: A Global Town Hall
8. The Global Leaders' Inaugural Meeting a Resounding Success
9. Language Service Leader Expands to Meet Booming, Global Industry Demand.
10. GenomeQuest Hosts Seminar Focused On Web-based Searching for Patent Information Across Global Sequence Databases
11. Global Nutrition Firm Takes Dose of SonicWALL to Boost Network Health
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... Hamden, CT (PRWEB) , ... December 07, 2016 , ... ... has prompted an outpouring of comments on social media that offer a rare glimpse ... adult psychiatrist, leading ADHD authority and New York Times bestselling author, has described people ...
(Date:12/7/2016)... ... 2016 , ... They are musicians and librarians, fashion designers and fitness instructors, ... New England and around the nation. What do they have in common? All have ... beautiful and compelling new photographic exhibit debuting Friday, December 9 at Logan International Airport ...
(Date:12/7/2016)... ... December 07, 2016 , ... ... is now promoting to the US market its advanced highly customizable contact technology ... and ODU TURNTAC®. These advanced technologies are ideal for a wide range of ...
(Date:12/7/2016)... ... December 07, 2016 , ... ... consultation services to residents in the Sacramento/Folsom region, is initiating a charity event ... , The Another Choice Another Chance treatment center in Sacramento works to provide ...
(Date:12/7/2016)... PA (PRWEB) , ... December 07, 2016 , ... One ... regular changing of the securement tape is painful for her. "This is why the ... to patients’ heads," she said. , They then created a prototype of the patent-pending ...
Breaking Medicine News(10 mins):
(Date:12/6/2016)... -- Anaplastic Oligoastrocytoma - Pipeline Review, H2 2016 ... and Healthcare disease pipeline guide Anaplastic Oligoastrocytoma – ... the Anaplastic Oligoastrocytoma (Oncology) pipeline landscape. Anaplastic ... two types of cells in the brain, called ... form a mass. These brain cells are known ...
(Date:12/6/2016)... YORK , Dec. 6, 2016  Nearly 30 ... suffer from the epidemic of diabetes. 1 ... have persistently elevated glucose levels (hyperglycemia) and significant glucose variability. ... developing serious complications, including cardiovascular events. If left untreated, ... damage and eye disease or blindness. 3 ...
(Date:12/6/2016)... Dec. 6, 2016  Arcturus Therapeutics, Inc. ("Arcturus" ... announced today that it entered into collaboration with ... for the treatment of NASH and other gastrointestinal ... platform LUNAR™ and UNA Oligomer chemistry. The financial ... long-standing commitment to and expertise in GI disorders, ...
Breaking Medicine Technology: